MADISON,
Wis., Oct. 31, 2023 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today its participation in
the 14th Annual Jefferies London
Healthcare Conference. The management team is scheduled to
participate in a presentation with moderated Q&A on
Wednesday, November 15th,
2023 at 9:00am GMT/4:00am EST.
A live webcast of the presentation can be
accessed on the Investor Relations section of the company's website
at investors.accuray.com. A webcast replay of the presentation
will be available on the company's website following the event and
will remain available for 90 days.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding
the powerful potential of radiation therapy to improve as many
lives as possible. We invent unique, market-changing solutions that
are designed to deliver radiation treatments for even the most
complex cases—while making commonly treatable cases even easier—to
meet the full spectrum of patient needs. We are dedicated to
continuous innovation in radiation therapy for oncology,
neuro-radiosurgery, and beyond, as we partner with clinicians and
administrators, empowering them to help patients get back to their
lives, faster. Accuray is headquartered
in Madison, Wisconsin, with facilities worldwide. To
learn more, visit www.accuray.com or follow us
on Facebook, LinkedIn, Twitter,
and YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-in-the-14th-annual-jefferies-london-healthcare-conference-301970973.html
SOURCE Accuray Incorporated